SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Regeneron Pharmaceuticals -- Ignore unavailable to you. Want to Upgrade?


To: Felix B who wrote (2213)11/23/2017 9:57:38 AM
From: Miljenko Zuanic  Respond to of 3559
 
At this point I can only say that it is an interesting target complementing (enhancing) allergic IL-4/13, but also inflammatory TNF-alpfa. So, opportunities are broad.

Yes, Kevzara is disappointment, will see can 2018 bring some excitement in sale numbers?